Versifel CVR

Country: United Kingdom

Bahasa: Inggeris

Sumber: VMD (Veterinary Medicines Directorate)

Bahan aktif:

Feline calicivirus, Feline panleukopenia virus, Feline viral rhinotracheitis virus

Boleh didapati daripada:

Zoetis UK Limited

Kod ATC:

QI06AD04

INN (Nama Antarabangsa):

Feline calicivirus, Feline panleukopenia virus, Feline viral rhinotracheitis virus

Borang farmaseutikal:

Powder and solvent for solution for injection

Jenis preskripsi:

POM-V - Prescription Only Medicine – Veterinarian

Kumpulan terapeutik:

Cats

Kawasan terapeutik:

Live Viral Vaccine

Status kebenaran:

Authorized

Tarikh kebenaran:

2010-02-12

Ciri produk

Revised: September 2021
AN: 00447/2021
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Versifel CVR
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each dose of 1 ml contains:
ACTIVE SUBSTANCES:
Live attenuated feline enteritis (panleucopaenia) virus (FPV), Snow
Leopard
strain, minimum titre: 10
3.0
CCID
50
*
Live attenuated feline rhinotracheitis virus (FVR), strain FVRm,
minimum titre:
10
5.0
CCID
50
*
Live attenuated calicivirus (FCV), strain F9, minimum titre: 10
5.5
CCID
50
*
* Cell culture infectious dose 50%
SOLVENT:
Water for injections.
For the full list of excipients, see Section 6.1.
3.
PHARMACEUTICAL FORM
Lyophilisate and solvent for solution for injection.
4.
CLINICAL PARTICULARS
4.1.
TARGET SPECIES
Cats from 9 weeks of age.
4.2.
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For active immunisation of cats to reduce mortality and clinical signs
of disease
caused by feline enteritis (panleucopaenia) virus, to reduce clinical
signs of
disease caused by feline rhinotracheitis virus and to prevent clinical
signs of
disease and reduce infection caused by feline calicivirus.
Onset of immunity occurs by approximately 3 weeks after the last dose
of the
Basic Vaccination Scheme.
The duration of immunity is at least 12 months.
4.3.
CONTRAINDICATIONS
None.
Revised: September 2021
AN: 00447/2021
Page 2 of 5
4.4.
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Vaccinate healthy animals only.
The feline panleucopaenia virus and the feline calicivirus vaccinal
strains may be
shed from vaccinated animals for a number of days following
vaccination.
However, due to the low pathogenicity of these strains, it is not
necessary to keep
vaccinated animals separated from non-vaccinated animals.
Moderate to high levels of maternally derived antibodies (MDA) may
interfere with
the response to vaccination.
4.5.
SPECIAL PRECAUTIONS FOR USE
i)
Special precautions for use in animals
None.
ii)
Special precautions to be taken by the person administering the
veterinary
medicinal product to animal